Expression of interleukin-6 and its clinicopathological significance in Castleman' s disease

AshrafA Kasem,Talal Al Thubaity
DOI: https://doi.org/10.3760/cma.j.issn.0253-2727.2013.05.006
2013-01-01
Abstract:Objective To evaluate the expression of interleukin-6 (IL-6) and its clinicopathological significance in Castleman' s disease (CD).Methods Clinical data and paraffin blocks of 92 CD patients and 20 cases of lymph node reactive hyperplasia (LRH) as a control group were collected from department of pathology of Peking University Health Science Center.The expression of IL-6 was detected by using immunohistochemical method.Results The 92 patients were composed of 42 multicentric variant (MCDs) and 50unicentric variant (UCDs) clinically,and 30 hyaline-vascular variant (HV-CDs) and 62 plasma cell variant (PC-CDs) morphologically.None of them was positive for HIV tests.There were 56 males and 36 females,and their ages ranged from 4 years to 90 years with the median 41 years.IL-6 was expressed in 77 (83.7%)of 92 CD cases and 1 (5.0%) of 20 LRH cases.The expression rate of IL-6 was 90.5% in MCDs,78.0%in UCDs,93.6% in PC-CDs and 63.4% in HV-CDs,respectively.PC-CD cases showed a significantly higher expression rate of IL-6 than HV-CD cases (P =0.001).All cases with positive IL-6 expression in plasmacytes were PC-CDs,showing obviously higher expression in MCDs than that in UCDs (P =0.003).Compared with HV-CD cases,much more PC-CD cases showed IL-6 positivity in endothelial cells (P =0.008).However,IL-6 was rarely expressed by both FDCs and macrophages,with only 3.3% and 10.9%positive cases,respectively.There are 53.2% (41/77) of the IL-6 positive cases and 20.0% (3/15) of IL-6 negative cases suffered from systemic symptoms,showing a significant difference between the two groups (P=0.018).Cases with IL-6 expression in plasmacytes and macrophages were more likely to suffer from systemic symptoms,especially B type symptoms (P < 0.05).Conclusions There is a high expression rate of IL-6 in CD,which is different from LRH.The expression of IL-6 has close relationship with CD subtypes and the presence of systemic symptoms.In all,the evaluation of interleukin-6 is of great value to guide the diagnosis and therapy of CD.
What problem does this paper attempt to address?